Vanda Pharmaceuticals Statistics
NASDAQ: VNDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.57+0.04 (+0.88%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 4.57 0.00%
Vanda Pharmaceuticals by the numbers
Vanda Pharmaceuticals has a market capitalization of $276.3 million based on 60.46M shares outstanding. With trailing EPS of $-4.63, Vanda Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.0% below its 50-day average and 29.6% below its 200-day average.
Average daily trading volume is 974.13K shares, or about $4.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VNDA valuation vs. peer median
| Metric | VNDA | Peer median | Difference |
|---|---|---|---|
| Market cap | $276.31M | $279.20M | -1% |
| Avg. volume | 974.13K | 1.09M | -11% |
Peer median across 8 companies: LRMR, BCYC, RCKT, ABEO, BBOT, FULC, VOGX, BIOA.
Valuation
- Market cap
- $276.31M
- Forward P/E
- 22.85
- EPS (TTM)
- $-4.63
- Shares outstanding
- 60.46M
Price and trading
- Previous close
- 4.53
- Open
- 4.51
- Day range
- 4.47 – 4.59
- 52-week range
- 4.27 – 9.94
- 52-week change
- -17.03%
- Beta
- —
- Volume
- 639.70K
- Average volume
- 974.13K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 276.31M
- Forward Pe
- 22.85
- Eps
- -4.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.94
- Week52 Low
- 4.27
- Avg Volume
- 974.13K
- Shares Outstanding
- 60.46M
- Ma50
- 5.13
- Ma200
- 6.49
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -54.02%
- Pct From52w Low
- 7.03%